Skip to main content

HEPARIN INTERPHARMA (Interpharma Pty Ltd)

Product name
HEPARIN INTERPHARMA
Date registered
Evaluation commenced
Decision date
Approval time
214 (255 working days)
Active ingredients
heparin sodium
Registration type
NCE/NBE
Indication

Prophylaxis and treatment of deep vein thrombosis for use in patients 18 years and older.

Help us improve the Therapeutic Goods Administration site